FGF7 and cancer: Notably, CD34, IL7R, NRP1, GZMB, FGF7, and ENO2 exhibited significant expression in cancer stem cells, CD4+ memory cells, regulatory T cells, NK cells, fibroblasts, and neurons, respectively (Figures 5B–G).